Gene · 11004
Papers1,860
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,860
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioinformatics Analysis and Screening of Potential Target Genes Related to the Lung Cancer Prognosis. | Med Princ Pract | 2023 | 37708874 | PubTator, text mining | PubMed |
| An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers. | Cancer Res Commun | 2023 | 37707389 | PubTator, text mining | PubMed |
| Prognostic value of cell division cycle-associated protein-3 in prostate cancer. | Medicine (Baltimore) | 2023 | 37682152 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer. | J Cancer | 2023 | 37670965 | PubTator, text mining | PubMed |
| Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma. | PeerJ | 2023 | 37663298 | PubTator, text mining | PubMed |
| Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches. | Front Genet | 2023 | 37662839 | PubTator, text mining | PubMed |
| Knockdown of KIF15 suppresses proliferation of prostate cancer cells and induces apoptosis through PI3K/Akt signaling pathway. | Cell Death Discov | 2023 | 37658042 | PubTator, text mining | PubMed |
| Lysosome-related genes: A new prognostic marker for lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37657029 | PubTator, text mining | PubMed |
| Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma. | Korean J Physiol Pharmacol | 2023 | 37641808 | PubTator, text mining | PubMed |
| An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma. | Med Sci Monit | 2023 | 37632137 | PubTator, text mining | PubMed |
| The minus-end depolymerase KIF2A drives flux-like treadmilling of γTuRC-uncapped microtubules. | J Cell Biol | 2023 | 37615667 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers. | Front Oncol | 2023 | 37601657 | PubTator, text mining | PubMed |
| TUBB3 and KIF21A in neurodevelopment and disease. | Front Neurosci | 2023 | 37600020 | PubTator, text mining | PubMed |
| Hornerin mediates phosphorylation of the polo-box domain in Plk1 by Chk1 to induce death in mitosis. | Cell Death Differ | 2023 | 37596441 | PubTator, text mining | PubMed |
| CEACAM1 as a molecular target in oral cancer. | Aging (Albany NY) | 2023 | 37589542 | PubTator, text mining | PubMed |
| The fate of extra centrosomes in newly formed tetraploid cells: should I stay, or should I go? | Front Cell Dev Biol | 2023 | 37576603 | PubTator, text mining | PubMed |
| High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation. | J Cancer | 2023 | 37576392 | PubTator, text mining | PubMed |
| KIF2C and receptor trafficking: Cerebellar synapses show the way. | J Physiol | 2023 | 37572019 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Prognostic Significance of the TRIM Family in the Context of TP53 Mutations in Cancers. | Cancers (Basel) | 2023 | 37568609 | PubTator, text mining | PubMed |
| New insights into the mechanochemical coupling mechanism of kinesin-microtubule complexes from their high-resolution structures. | Biochem Soc Trans | 2023 | 37560910 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11004/papers?page=9